| 0 |
DIAMINE OXIDASE DEFICIENCY |
1 |
0.2500 |
| 1 |
PATHOLOGICAL TOOTH FRACTURE |
1 |
0.1250 |
| 2 |
CARBOHYDRATE TOLERANCE DECREASED |
1 |
0.0455 |
| 3 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, MIXED TYPE |
1 |
0.0435 |
| 4 |
HYPOCHOLESTEROLAEMIA |
13 |
0.0368 |
| 5 |
SKIN LESION INFLAMMATION |
4 |
0.0303 |
| 6 |
APPLICATION SITE PALLOR |
1 |
0.0303 |
| 7 |
OSTEOMA CUTIS |
1 |
0.0294 |
| 8 |
PSYCHOLOGICAL FACTOR AFFECTING MEDICAL CONDITION |
1 |
0.0213 |
| 9 |
LACK OF INFUSION SITE ROTATION |
1 |
0.0208 |
| 10 |
PACEMAKER GENERATED RHYTHM |
1 |
0.0189 |
| 11 |
LUPUS VULGARIS |
22 |
0.0175 |
| 12 |
COMPLICATED FRACTURE |
1 |
0.0161 |
| 13 |
BLEPHAROSPASM |
95 |
0.0151 |
| 14 |
ACQUIRED PORPHYRIA |
1 |
0.0141 |
| 15 |
HEPATIC ENZYME |
2 |
0.0134 |
| 16 |
SUBCUTANEOUS DRUG ABSORPTION IMPAIRED |
7 |
0.0125 |
| 17 |
CHORIORETINAL SCAR |
1 |
0.0120 |
| 18 |
SWOLLEN JOINT COUNT |
3 |
0.0120 |
| 19 |
TENDER JOINT COUNT |
1 |
0.0119 |
| 20 |
TETHERED ORAL TISSUE |
1 |
0.0119 |
| 21 |
SPECIFIC GRAVITY URINE ABNORMAL |
1 |
0.0118 |
| 22 |
OVERLAP SYNDROME |
8 |
0.0114 |
| 23 |
MIXED INCONTINENCE |
1 |
0.0110 |
| 24 |
PELVIC ORGAN PROLAPSE |
1 |
0.0110 |
| 25 |
POSTOPERATIVE HERNIA |
1 |
0.0109 |
| 26 |
RHEUMATIC FEVER |
48 |
0.0108 |
| 27 |
FACET JOINT SYNDROME |
35 |
0.0107 |
| 28 |
ADMINISTRATION SITE DISCOMFORT |
2 |
0.0106 |
| 29 |
CARDIAC VALVE RUPTURE |
1 |
0.0098 |
| 30 |
SWOLLEN JOINT COUNT INCREASED |
31 |
0.0097 |
| 31 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE |
1 |
0.0095 |
| 32 |
CAROTID ARTERY ATHEROMA |
1 |
0.0094 |
| 33 |
PERIPHERAL VENOUS DISEASE |
38 |
0.0093 |
| 34 |
RETINITIS |
16 |
0.0093 |
| 35 |
DISLOCATION OF VERTEBRA |
21 |
0.0092 |
| 36 |
X-RAY ABNORMAL |
16 |
0.0089 |
| 37 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
18 |
0.0087 |
| 38 |
C-REACTIVE PROTEIN |
8 |
0.0086 |
| 39 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
17 |
0.0085 |
| 40 |
IRON METABOLISM DISORDER |
1 |
0.0084 |
| 41 |
BLEPHAROPLASTY |
1 |
0.0082 |
| 42 |
ONYCHOMADESIS |
28 |
0.0067 |
| 43 |
MALABSORPTION FROM APPLICATION SITE |
1 |
0.0065 |
| 44 |
SCAN MYOCARDIAL PERFUSION ABNORMAL |
1 |
0.0065 |
| 45 |
DIASTASIS RECTI ABDOMINIS |
1 |
0.0062 |
| 46 |
LUMBOSACRAL RADICULOPATHY |
1 |
0.0062 |
| 47 |
INFANTILE HAEMANGIOMA |
1 |
0.0062 |
| 48 |
INFUSION SITE REACTION |
18 |
0.0060 |
| 49 |
DOSING ERROR |
1 |
0.0060 |
| 50 |
LABELLED DRUG-FOOD INTERACTION ISSUE |
1 |
0.0059 |
| 51 |
SWELLING OF NOSE |
1 |
0.0058 |
| 52 |
BREAST CANCER STAGE III |
37 |
0.0057 |
| 53 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
40 |
0.0056 |
| 54 |
RICKETS |
1 |
0.0053 |
| 55 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
29 |
0.0052 |
| 56 |
ROSACEA |
23 |
0.0049 |
| 57 |
OCULAR ROSACEA |
1 |
0.0049 |
| 58 |
PORPHYRIA ACUTE |
7 |
0.0049 |
| 59 |
RHEUMATOID FACTOR POSITIVE |
28 |
0.0048 |
| 60 |
DUODENAL ULCER PERFORATION |
36 |
0.0048 |
| 61 |
PRODUCT ADVERTISING ISSUE |
1 |
0.0047 |
| 62 |
CHOLELITHOTOMY |
1 |
0.0046 |
| 63 |
TASTE DISORDER |
93 |
0.0046 |
| 64 |
MECHANICAL URTICARIA |
2 |
0.0043 |
| 65 |
FOLLICULITIS |
44 |
0.0042 |
| 66 |
LIVE BIRTH |
35 |
0.0042 |
| 67 |
KYPHOSCOLIOSIS |
1 |
0.0038 |
| 68 |
PALMOPLANTAR PUSTULOSIS |
2 |
0.0038 |
| 69 |
CHOLESTEATOMA |
1 |
0.0036 |
| 70 |
PRODUCT INFORMATION CONTENT COMPLAINT |
1 |
0.0036 |
| 71 |
SERONEGATIVE ARTHRITIS |
4 |
0.0035 |
| 72 |
BONE EROSION |
12 |
0.0034 |
| 73 |
ADENOMYOSIS |
2 |
0.0034 |
| 74 |
WOUND INFECTION |
36 |
0.0033 |
| 75 |
BACK INJURY |
35 |
0.0032 |
| 76 |
BURSITIS |
39 |
0.0032 |
| 77 |
CONDUCTIVE DEAFNESS |
1 |
0.0031 |
| 78 |
CELLULITE |
1 |
0.0031 |
| 79 |
BLOOD CREATINE PHOSPHOKINASE DECREASED |
1 |
0.0030 |
| 80 |
PSEUDOCIRRHOSIS |
1 |
0.0030 |
| 81 |
SALIVA DISCOLOURATION |
1 |
0.0030 |
| 82 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY |
2 |
0.0030 |
| 83 |
SYNOVITIS |
54 |
0.0030 |
| 84 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
33 |
0.0030 |
| 85 |
EXOSTOSIS |
27 |
0.0030 |
| 86 |
EPILEPSY |
90 |
0.0029 |
| 87 |
PSEUDOSTROKE |
1 |
0.0029 |
| 88 |
GASTROINTESTINAL MICROORGANISM OVERGROWTH |
1 |
0.0028 |
| 89 |
MULTIPLE SYSTEM ATROPHY |
1 |
0.0028 |
| 90 |
MUSCLE INJURY |
23 |
0.0028 |
| 91 |
GLOBULINS INCREASED |
1 |
0.0027 |
| 92 |
FEEDING TUBE USER |
1 |
0.0027 |
| 93 |
VITAMIN B COMPLEX DEFICIENCY |
2 |
0.0027 |
| 94 |
HYPERCHOLESTEROLAEMIA |
26 |
0.0027 |
| 95 |
C-REACTIVE PROTEIN ABNORMAL |
17 |
0.0026 |
| 96 |
PEMPHIGUS |
33 |
0.0026 |
| 97 |
PERICARDITIS |
44 |
0.0026 |
| 98 |
POLYCYSTIC OVARIAN SYNDROME |
1 |
0.0026 |
| 99 |
PREGNANCY TEST POSITIVE |
1 |
0.0025 |
| 100 |
DRUG TOLERANCE DECREASED |
7 |
0.0025 |
| 101 |
LIP DRY |
22 |
0.0024 |
| 102 |
HELICOBACTER INFECTION |
24 |
0.0023 |
| 103 |
SARCOPENIA |
1 |
0.0023 |
| 104 |
APPLICATION SITE PARAESTHESIA |
3 |
0.0023 |
| 105 |
SKIN LAXITY |
1 |
0.0023 |
| 106 |
PRODUCT WITH QUALITY ISSUE ADMINISTERED |
1 |
0.0022 |
| 107 |
JOINT RANGE OF MOTION DECREASED |
30 |
0.0022 |
| 108 |
STRESS SYMPTOMS |
1 |
0.0022 |
| 109 |
ALLERGY TO ARTHROPOD STING |
1 |
0.0022 |
| 110 |
INJURY ASPHYXIATION |
1 |
0.0022 |
| 111 |
BIOPSY BONE MARROW |
1 |
0.0021 |
| 112 |
MENINGISM |
1 |
0.0021 |
| 113 |
BLOOD CREATINE ABNORMAL |
1 |
0.0021 |
| 114 |
TELANGIECTASIA |
2 |
0.0021 |
| 115 |
PUSTULAR PSORIASIS |
7 |
0.0020 |
| 116 |
ROOT CANAL INFECTION |
1 |
0.0020 |
| 117 |
DERMATITIS INFECTED |
1 |
0.0020 |
| 118 |
HYPERMOBILITY SYNDROME |
1 |
0.0020 |
| 119 |
NAIL DISORDER |
17 |
0.0019 |
| 120 |
INTERVERTEBRAL DISC DISPLACEMENT |
1 |
0.0019 |
| 121 |
PHARYNGEAL MASS |
1 |
0.0019 |
| 122 |
COATING IN MOUTH |
1 |
0.0019 |
| 123 |
HAND DEFORMITY |
24 |
0.0018 |
| 124 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
31 |
0.0018 |
| 125 |
ONYCHOMYCOSIS |
8 |
0.0018 |
| 126 |
MILK ALLERGY |
1 |
0.0018 |
| 127 |
MITRAL VALVE PROLAPSE |
3 |
0.0018 |
| 128 |
MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED |
1 |
0.0018 |
| 129 |
JUGULAR VEIN DISTENSION |
1 |
0.0018 |
| 130 |
ACUTE SINUSITIS |
3 |
0.0017 |
| 131 |
EUSTACHIAN TUBE DYSFUNCTION |
1 |
0.0017 |
| 132 |
GRIP STRENGTH DECREASED |
15 |
0.0017 |
| 133 |
BREAST CANCER STAGE II |
14 |
0.0017 |
| 134 |
MALE SEXUAL DYSFUNCTION |
1 |
0.0017 |
| 135 |
RASH VESICULAR |
8 |
0.0017 |
| 136 |
ALLERGY TO METALS |
1 |
0.0016 |
| 137 |
CUTANEOUS VASCULITIS |
6 |
0.0016 |
| 138 |
WOUND |
45 |
0.0016 |
| 139 |
DERMATOSIS |
1 |
0.0016 |
| 140 |
PLEURAL DISORDER |
1 |
0.0016 |
| 141 |
BAND SENSATION |
2 |
0.0016 |
| 142 |
PERIORAL DERMATITIS |
1 |
0.0016 |
| 143 |
ACTIVITIES OF DAILY LIVING DECREASED |
1 |
0.0016 |
| 144 |
LUPUS-LIKE SYNDROME |
14 |
0.0015 |
| 145 |
CONTRAINDICATED PRODUCT ADMINISTERED |
46 |
0.0015 |
| 146 |
MAMMOGRAM ABNORMAL |
1 |
0.0015 |
| 147 |
IRRITABLE BOWEL SYNDROME |
32 |
0.0015 |
| 148 |
EYELID PAIN |
3 |
0.0015 |
| 149 |
NORMAL NEWBORN |
8 |
0.0015 |
| 150 |
CALCULUS BLADDER |
2 |
0.0015 |
| 151 |
CONGENITAL HAND MALFORMATION |
1 |
0.0015 |
| 152 |
HEAD TITUBATION |
2 |
0.0015 |
| 153 |
INGROWN HAIR |
1 |
0.0014 |
| 154 |
ARACHNOIDITIS |
1 |
0.0014 |
| 155 |
GLOSSODYNIA |
32 |
0.0014 |
| 156 |
CONGENITAL HYDRONEPHROSIS |
1 |
0.0014 |
| 157 |
CERVIX DISORDER |
1 |
0.0014 |
| 158 |
AMNIOTIC CAVITY INFECTION |
1 |
0.0014 |
| 159 |
GRAFT LOSS |
1 |
0.0014 |
| 160 |
RECALLED PRODUCT ADMINISTERED |
13 |
0.0014 |
| 161 |
FIBROMYALGIA |
33 |
0.0014 |
| 162 |
POOR QUALITY PRODUCT ADMINISTERED |
14 |
0.0013 |
| 163 |
ACNE CYSTIC |
4 |
0.0013 |
| 164 |
CHOLANGITIS ACUTE |
1 |
0.0013 |
| 165 |
EYE INJURY |
4 |
0.0013 |
| 166 |
NIGHT SWEATS |
42 |
0.0013 |
| 167 |
RED BLOOD CELL SEDIMENTATION RATE ABNORMAL |
3 |
0.0013 |
| 168 |
JOINT DESTRUCTION |
2 |
0.0013 |
| 169 |
GASTROOESOPHAGEAL REFLUX DISEASE |
102 |
0.0013 |
| 170 |
INTRACRANIAL PRESSURE INCREASED |
7 |
0.0013 |
| 171 |
SYSTEMIC LUPUS ERYTHEMATOSUS RASH |
1 |
0.0013 |
| 172 |
BREAST CALCIFICATIONS |
1 |
0.0013 |
| 173 |
LIP ERYTHEMA |
1 |
0.0013 |
| 174 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
8 |
0.0012 |
| 175 |
GENITAL INFECTION FUNGAL |
1 |
0.0012 |
| 176 |
GIANT CELL ARTERITIS |
1 |
0.0012 |
| 177 |
MEDICAL PROCEDURE |
2 |
0.0012 |
| 178 |
OBESITY |
19 |
0.0012 |
| 179 |
ULCER HAEMORRHAGE |
8 |
0.0012 |
| 180 |
CERVICAL SPINAL STENOSIS |
2 |
0.0012 |
| 181 |
ENDOCRINE OPHTHALMOPATHY |
1 |
0.0012 |
| 182 |
INFUSION SITE DISCOLOURATION |
1 |
0.0011 |
| 183 |
AUTOIMMUNE DISORDER |
11 |
0.0011 |
| 184 |
PAPILLOEDEMA |
5 |
0.0011 |
| 185 |
SPONDYLITIS |
4 |
0.0011 |
| 186 |
C-REACTIVE PROTEIN INCREASED |
40 |
0.0011 |
| 187 |
MIGRAINE |
101 |
0.0011 |
| 188 |
SOLAR LENTIGO |
1 |
0.0011 |
| 189 |
SKIN TEXTURE ABNORMAL |
1 |
0.0010 |
| 190 |
INFUSION SITE NODULE |
1 |
0.0010 |
| 191 |
HYPERTONIC BLADDER |
3 |
0.0010 |
| 192 |
IMPAIRED HEALING |
34 |
0.0010 |
| 193 |
FINGER DEFORMITY |
5 |
0.0010 |
| 194 |
CUTANEOUS LUPUS ERYTHEMATOSUS |
2 |
0.0010 |
| 195 |
GALLBLADDER INJURY |
2 |
0.0010 |
| 196 |
GAIT INABILITY |
33 |
0.0010 |
| 197 |
PSORIATIC ARTHROPATHY |
40 |
0.0010 |
| 198 |
LIGHT CHAIN ANALYSIS INCREASED |
1 |
0.0010 |
| 199 |
INFUSION SITE DISCOMFORT |
1 |
0.0010 |
| 200 |
EYELIDS PRURITUS |
3 |
0.0010 |
| 201 |
TYPE 2 DIABETES MELLITUS |
32 |
0.0009 |
| 202 |
DRUG INTOLERANCE |
91 |
0.0009 |
| 203 |
STRESS URINARY INCONTINENCE |
1 |
0.0009 |
| 204 |
PRESCRIBED OVERDOSE |
18 |
0.0009 |
| 205 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
33 |
0.0009 |
| 206 |
INFUSION SITE MASS |
1 |
0.0009 |
| 207 |
PILOERECTION |
1 |
0.0009 |
| 208 |
AORTIC DILATATION |
1 |
0.0009 |
| 209 |
CATHETER SITE DISCHARGE |
1 |
0.0009 |
| 210 |
GASTROINTESTINAL BACTERIAL INFECTION |
1 |
0.0009 |
| 211 |
EAR PAIN |
17 |
0.0009 |
| 212 |
POLYDACTYLY |
1 |
0.0009 |
| 213 |
INFUSION SITE INFECTION |
2 |
0.0009 |
| 214 |
PRESCRIBED UNDERDOSE |
17 |
0.0009 |
| 215 |
HEPATIC CIRRHOSIS |
16 |
0.0009 |
| 216 |
STOMATITIS |
51 |
0.0008 |
| 217 |
SUBCUTANEOUS ABSCESS |
4 |
0.0008 |
| 218 |
INFLAMMATION |
43 |
0.0008 |
| 219 |
BRONCHIAL HYPERREACTIVITY |
1 |
0.0008 |
| 220 |
OSTEOARTHRITIS |
35 |
0.0008 |
| 221 |
INFUSION SITE WARMTH |
1 |
0.0008 |
| 222 |
BLOOD ELECTROLYTES ABNORMAL |
1 |
0.0008 |
| 223 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
36 |
0.0008 |
| 224 |
RESPIRATORY DISORDER |
24 |
0.0008 |
| 225 |
BENIGN INTRACRANIAL HYPERTENSION |
1 |
0.0008 |
| 226 |
BLOOD CHOLESTEROL INCREASED |
37 |
0.0008 |
| 227 |
BLISTER |
44 |
0.0008 |
| 228 |
SLEEP DISORDER |
55 |
0.0008 |
| 229 |
EPIGASTRIC DISCOMFORT |
3 |
0.0008 |
| 230 |
POSTMENOPAUSAL HAEMORRHAGE |
2 |
0.0008 |
| 231 |
WALKING AID USER |
5 |
0.0008 |
| 232 |
ACROCHORDON |
1 |
0.0008 |
| 233 |
INTERCEPTED PRODUCT PRESCRIBING ERROR |
1 |
0.0008 |
| 234 |
SCIATICA |
12 |
0.0008 |
| 235 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
1 |
0.0007 |
| 236 |
SPINAL FUSION SURGERY |
3 |
0.0007 |
| 237 |
LIP BLISTER |
2 |
0.0007 |
| 238 |
LIVER INJURY |
18 |
0.0007 |
| 239 |
LOWER LIMB FRACTURE |
14 |
0.0007 |
| 240 |
NASAL DISCHARGE DISCOLOURATION |
1 |
0.0007 |
| 241 |
MEMORY IMPAIRMENT |
99 |
0.0007 |
| 242 |
INCISIONAL HERNIA |
1 |
0.0007 |
| 243 |
CHRONIC FATIGUE SYNDROME |
1 |
0.0007 |
| 244 |
THERAPEUTIC PROCEDURE |
1 |
0.0007 |
| 245 |
HALLUCINATIONS, MIXED |
3 |
0.0007 |
| 246 |
GLOMERULAR FILTRATION RATE ABNORMAL |
1 |
0.0007 |
| 247 |
CONNECTIVE TISSUE DISORDER |
1 |
0.0007 |
| 248 |
HAEMORRHAGE IN PREGNANCY |
1 |
0.0007 |
| 249 |
EYELID MARGIN CRUSTING |
2 |
0.0007 |
| 250 |
PRODUCT LABEL CONFUSION |
4 |
0.0007 |
| 251 |
INFUSION SITE INDURATION |
1 |
0.0007 |
| 252 |
GENERAL SYMPTOM |
5 |
0.0007 |
| 253 |
MATERNAL EXPOSURE DURING PREGNANCY |
59 |
0.0007 |
| 254 |
MYOCLONIC EPILEPSY |
1 |
0.0007 |
| 255 |
AGE-RELATED MACULAR DEGENERATION |
1 |
0.0007 |
| 256 |
DERMATITIS ACNEIFORM |
4 |
0.0007 |
| 257 |
HYPOAESTHESIA |
98 |
0.0007 |
| 258 |
RUBBER SENSITIVITY |
1 |
0.0007 |
| 259 |
LIVER FUNCTION TEST INCREASED |
14 |
0.0007 |
| 260 |
PREMATURE SEPARATION OF PLACENTA |
1 |
0.0006 |
| 261 |
PORTAL HYPERTENSION |
2 |
0.0006 |
| 262 |
PARAESTHESIA |
102 |
0.0006 |
| 263 |
POLYCYSTIC OVARIES |
1 |
0.0006 |
| 264 |
BACTERIAL VAGINOSIS |
1 |
0.0006 |
| 265 |
PRODUCT ADMINISTRATION INTERRUPTED |
5 |
0.0006 |
| 266 |
GESTATIONAL DIABETES |
3 |
0.0006 |
| 267 |
FREQUENT BOWEL MOVEMENTS |
17 |
0.0006 |
| 268 |
PULMONARY FIBROSIS |
12 |
0.0006 |
| 269 |
COSTOCHONDRITIS |
1 |
0.0006 |
| 270 |
ARTHROPATHY |
34 |
0.0006 |
| 271 |
APPLICATION SITE BURN |
3 |
0.0006 |
| 272 |
INFUSION SITE HAEMORRHAGE |
2 |
0.0006 |
| 273 |
WHEEZING |
36 |
0.0006 |
| 274 |
INTERCEPTED PRODUCT DISPENSING ERROR |
1 |
0.0006 |
| 275 |
DRUG TOLERANCE |
3 |
0.0006 |
| 276 |
DRY MOUTH |
48 |
0.0006 |
| 277 |
PRODUCT CONTAINER ISSUE |
5 |
0.0006 |
| 278 |
TACHYPHRENIA |
2 |
0.0006 |
| 279 |
PRODUCT CONTAINER SEAL ISSUE |
1 |
0.0006 |
| 280 |
SPLENIC INFARCTION |
1 |
0.0006 |
| 281 |
LUNG DISORDER |
28 |
0.0006 |
| 282 |
SKIN HYPOPIGMENTATION |
1 |
0.0006 |
| 283 |
TERMINAL INSOMNIA |
1 |
0.0006 |
| 284 |
MACULOPATHY |
2 |
0.0006 |
| 285 |
SKIN WEEPING |
2 |
0.0006 |
| 286 |
MYOSITIS |
5 |
0.0006 |
| 287 |
APPLICATION SITE DISCOMFORT |
1 |
0.0006 |
| 288 |
DEVICE ALARM ISSUE |
1 |
0.0006 |
| 289 |
SUSPECTED PRODUCT QUALITY ISSUE |
1 |
0.0005 |
| 290 |
SINUS NODE DYSFUNCTION |
1 |
0.0005 |
| 291 |
NECK PAIN |
30 |
0.0005 |
| 292 |
ABDOMINAL PAIN UPPER |
110 |
0.0005 |
| 293 |
NASAL OBSTRUCTION |
1 |
0.0005 |
| 294 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
2 |
0.0005 |
| 295 |
PERIORBITAL SWELLING |
3 |
0.0005 |
| 296 |
SACROILIITIS |
1 |
0.0005 |
| 297 |
LIP DISORDER |
1 |
0.0005 |
| 298 |
HEPATIC MASS |
1 |
0.0005 |
| 299 |
CONGENITAL ANOMALY |
4 |
0.0005 |
| 300 |
EARLY SATIETY |
1 |
0.0005 |
| 301 |
SWELLING |
48 |
0.0005 |
| 302 |
ADRENOCORTICAL INSUFFICIENCY ACUTE |
1 |
0.0005 |
| 303 |
OCCULT BLOOD POSITIVE |
1 |
0.0005 |
| 304 |
ALLERGIC REACTION TO EXCIPIENT |
1 |
0.0005 |
| 305 |
ANORECTAL DISORDER |
1 |
0.0005 |
| 306 |
APPLICATION SITE PAIN |
11 |
0.0005 |
| 307 |
HEPATIC ENZYME INCREASED |
34 |
0.0005 |
| 308 |
MUSCULOSKELETAL PAIN |
26 |
0.0005 |
| 309 |
JOINT STIFFNESS |
13 |
0.0005 |
| 310 |
TREATMENT FAILURE |
41 |
0.0005 |
| 311 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
35 |
0.0005 |
| 312 |
DELIRIUM |
17 |
0.0005 |
| 313 |
INFUSION RELATED REACTION |
32 |
0.0005 |
| 314 |
HYPOSPADIAS |
1 |
0.0005 |
| 315 |
LIVEDO RETICULARIS |
1 |
0.0005 |
| 316 |
RHEUMATOID ARTHRITIS |
54 |
0.0005 |
| 317 |
JOINT DISLOCATION |
5 |
0.0005 |
| 318 |
ESCHERICHIA URINARY TRACT INFECTION |
2 |
0.0005 |
| 319 |
SHOULDER OPERATION |
2 |
0.0005 |
| 320 |
CATHETER SITE ERYTHEMA |
1 |
0.0005 |
| 321 |
DEREALISATION |
1 |
0.0005 |
| 322 |
BLOOD MAGNESIUM DECREASED |
4 |
0.0005 |
| 323 |
OSTEOPOROSIS |
19 |
0.0005 |
| 324 |
GASTRIC BYPASS |
1 |
0.0005 |
| 325 |
CERVICAL DYSPLASIA |
1 |
0.0005 |
| 326 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
1 |
0.0005 |
| 327 |
ENDOMETRIAL CANCER |
1 |
0.0005 |
| 328 |
MIDDLE EAR EFFUSION |
1 |
0.0005 |
| 329 |
FOOT DEFORMITY |
5 |
0.0005 |
| 330 |
IDIOPATHIC INTRACRANIAL HYPERTENSION |
1 |
0.0004 |
| 331 |
INJURY |
31 |
0.0004 |
| 332 |
LOWER RESPIRATORY TRACT INFECTION |
20 |
0.0004 |
| 333 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
3 |
0.0004 |
| 334 |
BRAIN OPERATION |
1 |
0.0004 |
| 335 |
AUTOIMMUNE HEPATITIS |
3 |
0.0004 |
| 336 |
SINUS PAIN |
1 |
0.0004 |
| 337 |
SKIN ABRASION |
2 |
0.0004 |
| 338 |
PUSTULE |
1 |
0.0004 |
| 339 |
PRODUCT USE IN UNAPPROVED INDICATION |
103 |
0.0004 |
| 340 |
SKIN IRRITATION |
19 |
0.0004 |
| 341 |
HAEMATOLOGICAL INFECTION |
1 |
0.0004 |
| 342 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
7 |
0.0004 |
| 343 |
COELIAC DISEASE |
4 |
0.0004 |
| 344 |
SENSITIVE SKIN |
3 |
0.0004 |
| 345 |
GASTROINTESTINAL TUBE INSERTION |
1 |
0.0004 |
| 346 |
CHEMICAL BURN OF SKIN |
1 |
0.0004 |
| 347 |
ENDODONTIC PROCEDURE |
1 |
0.0004 |
| 348 |
DISCOMFORT |
24 |
0.0004 |
| 349 |
INSURANCE ISSUE |
6 |
0.0004 |
| 350 |
ABNORMAL UTERINE BLEEDING |
1 |
0.0004 |
| 351 |
GENERAL PHYSICAL HEALTH DETERIORATION |
45 |
0.0004 |
| 352 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
3 |
0.0004 |
| 353 |
CATHETER SITE PAIN |
1 |
0.0004 |
| 354 |
BASAL CELL CARCINOMA |
6 |
0.0004 |
| 355 |
PRODUCT QUALITY ISSUE |
52 |
0.0004 |
| 356 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
1 |
0.0004 |
| 357 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
1 |
0.0004 |
| 358 |
ANAESTHETIC COMPLICATION |
1 |
0.0004 |
| 359 |
PRODUCT RESIDUE PRESENT |
2 |
0.0004 |
| 360 |
BLOOD SODIUM INCREASED |
1 |
0.0004 |
| 361 |
CHONDROPATHY |
1 |
0.0004 |
| 362 |
PRODUCT PRESCRIBING ISSUE |
8 |
0.0004 |
| 363 |
UPPER-AIRWAY COUGH SYNDROME |
3 |
0.0004 |
| 364 |
HEART RATE ABNORMAL |
2 |
0.0004 |
| 365 |
PRODUCT LEAKAGE |
2 |
0.0004 |
| 366 |
SWELLING FACE |
23 |
0.0004 |
| 367 |
OESOPHAGEAL STENOSIS |
1 |
0.0004 |
| 368 |
BILIARY COLIC |
1 |
0.0003 |
| 369 |
SKIN WARM |
2 |
0.0003 |
| 370 |
LUMBAR SPINAL STENOSIS |
1 |
0.0003 |
| 371 |
GLUCOSE TOLERANCE IMPAIRED |
2 |
0.0003 |
| 372 |
SINUS HEADACHE |
2 |
0.0003 |
| 373 |
ADRENAL INSUFFICIENCY |
4 |
0.0003 |
| 374 |
HIP ARTHROPLASTY |
5 |
0.0003 |
| 375 |
EXPOSURE DURING PREGNANCY |
20 |
0.0003 |
| 376 |
SWELLING OF EYELID |
2 |
0.0003 |
| 377 |
INFUSION SITE PRURITUS |
1 |
0.0003 |
| 378 |
ELECTROENCEPHALOGRAM ABNORMAL |
1 |
0.0003 |
| 379 |
BLADDER PAIN |
1 |
0.0003 |
| 380 |
POLYMYALGIA RHEUMATICA |
1 |
0.0003 |
| 381 |
ILL-DEFINED DISORDER |
19 |
0.0003 |
| 382 |
THERAPY NON-RESPONDER |
14 |
0.0003 |
| 383 |
PRODUCT USE ISSUE |
58 |
0.0003 |
| 384 |
INTENTIONAL PRODUCT USE ISSUE |
27 |
0.0003 |
| 385 |
BACK DISORDER |
5 |
0.0003 |
| 386 |
AMNESIA |
20 |
0.0003 |
| 387 |
LYMPHOCYTE COUNT INCREASED |
1 |
0.0003 |
| 388 |
SOMNAMBULISM |
2 |
0.0003 |
| 389 |
DEAFNESS NEUROSENSORY |
1 |
0.0003 |
| 390 |
OTITIS MEDIA |
1 |
0.0003 |
| 391 |
PEPTIC ULCER |
1 |
0.0003 |
| 392 |
GASTROINTESTINAL DISORDER |
27 |
0.0003 |
| 393 |
JOINT SWELLING |
36 |
0.0003 |
| 394 |
APPLICATION SITE DRYNESS |
1 |
0.0003 |
| 395 |
MOBILITY DECREASED |
21 |
0.0003 |
| 396 |
ECCHYMOSIS |
2 |
0.0003 |
| 397 |
HYPERTRANSAMINASAEMIA |
2 |
0.0003 |
| 398 |
URTICARIA |
48 |
0.0003 |
| 399 |
CAROTID ARTERY STENOSIS |
1 |
0.0003 |
| 400 |
PERIPHERAL SWELLING |
44 |
0.0003 |
| 401 |
THERMAL BURN |
2 |
0.0003 |
| 402 |
MUSCULAR WEAKNESS |
32 |
0.0003 |
| 403 |
SKIN BURNING SENSATION |
20 |
0.0003 |
| 404 |
FEELING HOT |
17 |
0.0003 |
| 405 |
OEDEMA |
15 |
0.0003 |
| 406 |
ASPIRATION |
3 |
0.0003 |
| 407 |
FOOD INTOLERANCE |
1 |
0.0003 |
| 408 |
IMMUNE-MEDIATED ENTEROCOLITIS |
1 |
0.0003 |
| 409 |
DRUG EFFECT LESS THAN EXPECTED |
4 |
0.0003 |
| 410 |
ARTHROPOD BITE |
2 |
0.0003 |
| 411 |
RETINOPATHY |
1 |
0.0003 |
| 412 |
CHRONIC SINUSITIS |
1 |
0.0003 |
| 413 |
CONFUSIONAL STATE |
43 |
0.0003 |
| 414 |
APHASIA |
8 |
0.0003 |
| 415 |
AUTOIMMUNE THYROIDITIS |
1 |
0.0003 |
| 416 |
SNORING |
1 |
0.0003 |
| 417 |
DERMATITIS CONTACT |
3 |
0.0003 |
| 418 |
ROAD TRAFFIC ACCIDENT |
11 |
0.0003 |
| 419 |
ABDOMINAL DISCOMFORT |
44 |
0.0003 |
| 420 |
PROCEDURAL COMPLICATION |
2 |
0.0003 |
| 421 |
CONTUSION |
25 |
0.0003 |
| 422 |
FOOD ALLERGY |
2 |
0.0003 |
| 423 |
CONCUSSION |
2 |
0.0003 |
| 424 |
PANIC DISORDER |
1 |
0.0003 |
| 425 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
1 |
0.0003 |
| 426 |
SENSATION OF HEAVINESS |
1 |
0.0003 |
| 427 |
SPLENOMEGALY |
3 |
0.0003 |
| 428 |
DRUG-INDUCED LIVER INJURY |
8 |
0.0003 |
| 429 |
DISABILITY |
5 |
0.0003 |
| 430 |
SKIN PAPILLOMA |
1 |
0.0002 |
| 431 |
BLEPHARITIS |
1 |
0.0002 |
| 432 |
ENURESIS |
1 |
0.0002 |
| 433 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
1 |
0.0002 |
| 434 |
RECURRENT CANCER |
1 |
0.0002 |
| 435 |
ADVERSE DRUG REACTION |
22 |
0.0002 |
| 436 |
GENERALISED OEDEMA |
3 |
0.0002 |
| 437 |
MENSTRUAL DISORDER |
2 |
0.0002 |
| 438 |
WEIGHT INCREASED |
54 |
0.0002 |
| 439 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
1 |
0.0002 |
| 440 |
KNEE ARTHROPLASTY |
5 |
0.0002 |
| 441 |
INFUSION SITE ERYTHEMA |
2 |
0.0002 |
| 442 |
LABORATORY TEST ABNORMAL |
7 |
0.0002 |
| 443 |
SKIN PLAQUE |
2 |
0.0002 |
| 444 |
ABSCESS LIMB |
1 |
0.0002 |
| 445 |
WHITE BLOOD CELL COUNT INCREASED |
9 |
0.0002 |
| 446 |
HEPATIC PAIN |
1 |
0.0002 |
| 447 |
INTERVERTEBRAL DISC DISORDER |
1 |
0.0002 |
| 448 |
PURULENT DISCHARGE |
1 |
0.0002 |
| 449 |
VOMITING |
110 |
0.0002 |
| 450 |
DEPRESSION |
53 |
0.0002 |
| 451 |
INFUSION SITE PAIN |
3 |
0.0002 |
| 452 |
SKIN HYPERPIGMENTATION |
2 |
0.0002 |
| 453 |
HYSTERECTOMY |
2 |
0.0002 |
| 454 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
5 |
0.0002 |
| 455 |
CHAPPED LIPS |
1 |
0.0002 |
| 456 |
MELANOCYTIC NAEVUS |
1 |
0.0002 |
| 457 |
BLOOD CALCIUM INCREASED |
2 |
0.0002 |
| 458 |
ORAL CANDIDIASIS |
3 |
0.0002 |
| 459 |
SPINAL OSTEOARTHRITIS |
2 |
0.0002 |
| 460 |
ADVERSE REACTION |
3 |
0.0002 |
| 461 |
LIVER DISORDER |
10 |
0.0002 |
| 462 |
EAR INFECTION |
6 |
0.0002 |
| 463 |
RHINITIS ALLERGIC |
1 |
0.0002 |
| 464 |
SINUSITIS |
23 |
0.0002 |
| 465 |
ACNE |
17 |
0.0002 |
| 466 |
FACIAL PAIN |
2 |
0.0002 |
| 467 |
MALIGNANT MELANOMA |
3 |
0.0002 |
| 468 |
GASTROINTESTINAL INFECTION |
2 |
0.0002 |
| 469 |
RASH |
96 |
0.0002 |
| 470 |
BLOOD PRESSURE SYSTOLIC DECREASED |
1 |
0.0002 |
| 471 |
HAEMOGLOBIN INCREASED |
1 |
0.0002 |
| 472 |
SKIN LESION |
6 |
0.0002 |
| 473 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
12 |
0.0002 |
| 474 |
DRY SKIN |
29 |
0.0002 |
| 475 |
EYE OPERATION |
1 |
0.0002 |
| 476 |
BLOOD CHOLESTEROL ABNORMAL |
1 |
0.0002 |
| 477 |
INTERVERTEBRAL DISC DEGENERATION |
2 |
0.0002 |
| 478 |
MEDICATION ERROR |
12 |
0.0002 |
| 479 |
PAIN |
131 |
0.0002 |
| 480 |
SKIN TIGHTNESS |
1 |
0.0002 |
| 481 |
ASTHMA |
24 |
0.0002 |
| 482 |
SARCOIDOSIS |
1 |
0.0002 |
| 483 |
PRE-ECLAMPSIA |
1 |
0.0002 |
| 484 |
LIP SWELLING |
7 |
0.0002 |
| 485 |
ENDOMETRIOSIS |
1 |
0.0002 |
| 486 |
RECTAL HAEMORRHAGE |
9 |
0.0002 |
| 487 |
SUPRAVENTRICULAR TACHYCARDIA |
2 |
0.0002 |
| 488 |
ALOPECIA |
41 |
0.0002 |
| 489 |
IMPAIRED QUALITY OF LIFE |
3 |
0.0002 |
| 490 |
DERMATITIS ATOPIC |
11 |
0.0002 |
| 491 |
LIMB OPERATION |
1 |
0.0002 |
| 492 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
10 |
0.0002 |
| 493 |
GUILLAIN-BARRE SYNDROME |
1 |
0.0002 |
| 494 |
SKIN FISSURES |
4 |
0.0002 |
| 495 |
THERAPY CHANGE |
2 |
0.0002 |
| 496 |
DYSPEPSIA |
20 |
0.0002 |
| 497 |
NASAL POLYPS |
1 |
0.0002 |
| 498 |
SMALL FOR DATES BABY |
1 |
0.0002 |
| 499 |
APPLICATION SITE SWELLING |
1 |
0.0002 |
| 500 |
CORONARY ARTERY STENOSIS |
1 |
0.0002 |
| 501 |
CORONARY ARTERIAL STENT INSERTION |
1 |
0.0002 |
| 502 |
PATHOLOGICAL FRACTURE |
1 |
0.0002 |
| 503 |
DRUG LEVEL DECREASED |
2 |
0.0002 |
| 504 |
MUSCLE SPASMS |
36 |
0.0002 |
| 505 |
PHLEBITIS |
1 |
0.0002 |
| 506 |
PERIPHERAL VASCULAR DISORDER |
1 |
0.0002 |
| 507 |
SKIN NECROSIS |
1 |
0.0002 |
| 508 |
PERIORBITAL OEDEMA |
1 |
0.0002 |
| 509 |
MALABSORPTION |
1 |
0.0002 |
| 510 |
APLASTIC ANAEMIA |
1 |
0.0002 |
| 511 |
BRAIN FOG |
3 |
0.0002 |
| 512 |
WEIGHT FLUCTUATION |
2 |
0.0002 |
| 513 |
APPLICATION SITE ERYTHEMA |
5 |
0.0002 |
| 514 |
SENSITIVITY TO WEATHER CHANGE |
1 |
0.0002 |
| 515 |
POLYARTHRITIS |
1 |
0.0002 |
| 516 |
INCONTINENCE |
2 |
0.0002 |
| 517 |
RESPIRATORY TRACT CONGESTION |
3 |
0.0002 |
| 518 |
FOOD POISONING |
1 |
0.0002 |
| 519 |
COMPRESSION FRACTURE |
1 |
0.0002 |
| 520 |
HEREDITARY ANGIOEDEMA |
2 |
0.0002 |
| 521 |
OVERWEIGHT |
1 |
0.0002 |
| 522 |
PRODUCT SIZE ISSUE |
1 |
0.0002 |
| 523 |
BEHAVIOUR DISORDER |
1 |
0.0002 |
| 524 |
CHEILITIS |
1 |
0.0002 |
| 525 |
ERYTHEMA OF EYELID |
1 |
0.0002 |
| 526 |
RASH PRURITIC |
10 |
0.0002 |
| 527 |
ADVERSE EVENT |
17 |
0.0002 |
| 528 |
CONDITION AGGRAVATED |
56 |
0.0002 |
| 529 |
HYDROCEPHALUS |
1 |
0.0002 |
| 530 |
MUSCULOSKELETAL STIFFNESS |
16 |
0.0002 |
| 531 |
NONSPECIFIC REACTION |
1 |
0.0002 |
| 532 |
GASTROINTESTINAL PAIN |
2 |
0.0002 |
| 533 |
DRY EYE |
9 |
0.0002 |
| 534 |
BLOOD UREA INCREASED |
3 |
0.0002 |
| 535 |
COLITIS ULCERATIVE |
8 |
0.0002 |
| 536 |
OCULAR DISCOMFORT |
2 |
0.0002 |
| 537 |
EYE INFECTION |
2 |
0.0002 |
| 538 |
CHOLECYSTITIS ACUTE |
1 |
0.0002 |
| 539 |
CHOLECYSTECTOMY |
2 |
0.0002 |
| 540 |
EXERCISE TOLERANCE DECREASED |
1 |
0.0002 |
| 541 |
SOCIAL AVOIDANT BEHAVIOUR |
1 |
0.0002 |
| 542 |
BURNING SENSATION |
12 |
0.0002 |
| 543 |
SURGERY |
10 |
0.0002 |
| 544 |
VISUAL IMPAIRMENT |
21 |
0.0002 |
| 545 |
BLOOD IRON DECREASED |
2 |
0.0002 |
| 546 |
CHOLECYSTITIS |
2 |
0.0002 |
| 547 |
HYPERLIPIDAEMIA |
2 |
0.0002 |
| 548 |
SYMPTOM RECURRENCE |
1 |
0.0002 |
| 549 |
COMPLICATION OF DEVICE REMOVAL |
3 |
0.0002 |
| 550 |
SQUAMOUS CELL CARCINOMA OF SKIN |
1 |
0.0002 |
| 551 |
DECREASED APPETITE |
38 |
0.0002 |
| 552 |
MUSCLE SPASTICITY |
2 |
0.0002 |
| 553 |
PIGMENTATION DISORDER |
1 |
0.0002 |
| 554 |
PHARYNGITIS |
2 |
0.0002 |
| 555 |
APPLICATION SITE IRRITATION |
2 |
0.0002 |
| 556 |
PRE-EXISTING CONDITION IMPROVED |
1 |
0.0002 |
| 557 |
SWOLLEN TONGUE |
5 |
0.0002 |
| 558 |
POISONING |
2 |
0.0002 |
| 559 |
INFUSION SITE SWELLING |
1 |
0.0002 |
| 560 |
FLUID RETENTION |
8 |
0.0002 |
| 561 |
EYE IRRITATION |
9 |
0.0002 |
| 562 |
HEPATITIS |
4 |
0.0002 |
| 563 |
EXPOSURE VIA SKIN CONTACT |
4 |
0.0002 |
| 564 |
ANGINA UNSTABLE |
1 |
0.0002 |
| 565 |
ORAL HERPES |
3 |
0.0002 |
| 566 |
ECZEMA |
8 |
0.0002 |
| 567 |
NEPHROLITHIASIS |
7 |
0.0002 |
| 568 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 569 |
NASOPHARYNGITIS |
28 |
0.0002 |
| 570 |
DYSGRAPHIA |
1 |
0.0002 |
| 571 |
PRODUCT FORMULATION ISSUE |
1 |
0.0002 |
| 572 |
PANCREATITIS |
8 |
0.0002 |
| 573 |
CHEST PAIN |
28 |
0.0002 |
| 574 |
CARDIAC FAILURE ACUTE |
1 |
0.0001 |
| 575 |
PREGNANCY |
3 |
0.0001 |
| 576 |
SKIN MASS |
1 |
0.0001 |
| 577 |
HAIR TEXTURE ABNORMAL |
2 |
0.0001 |
| 578 |
CHOLECYSTITIS CHRONIC |
1 |
0.0001 |
| 579 |
POST-TRAUMATIC STRESS DISORDER |
1 |
0.0001 |
| 580 |
BREAST MASS |
1 |
0.0001 |
| 581 |
EYE PRURITUS |
5 |
0.0001 |
| 582 |
PRODUCT ADMINISTRATION ERROR |
3 |
0.0001 |
| 583 |
COLITIS ISCHAEMIC |
1 |
0.0001 |
| 584 |
METASTASES TO LYMPH NODES |
1 |
0.0001 |
| 585 |
SINUS CONGESTION |
2 |
0.0001 |
| 586 |
BLOOD TESTOSTERONE DECREASED |
1 |
0.0001 |
| 587 |
CROHN'S DISEASE |
1 |
0.0001 |
| 588 |
ONYCHOCLASIS |
1 |
0.0001 |
| 589 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 590 |
ENCEPHALITIS |
1 |
0.0001 |
| 591 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
26 |
0.0001 |
| 592 |
HYPOMAGNESAEMIA |
2 |
0.0001 |
| 593 |
APPLICATION SITE REACTION |
1 |
0.0001 |
| 594 |
SKIN REACTION |
2 |
0.0001 |
| 595 |
BLINDNESS UNILATERAL |
2 |
0.0001 |
| 596 |
DUODENAL ULCER |
1 |
0.0001 |
| 597 |
SEASONAL ALLERGY |
2 |
0.0001 |
| 598 |
PRODUCT DOSE OMISSION IN ERROR |
4 |
0.0001 |
| 599 |
HAND FRACTURE |
1 |
0.0001 |
| 600 |
THERAPY INTERRUPTED |
10 |
0.0001 |
| 601 |
DERMATITIS BULLOUS |
1 |
0.0001 |
| 602 |
FAECES SOFT |
1 |
0.0001 |
| 603 |
LIQUID PRODUCT PHYSICAL ISSUE |
1 |
0.0001 |
| 604 |
INTENTIONAL UNDERDOSE |
1 |
0.0001 |
| 605 |
MAJOR DEPRESSION |
1 |
0.0001 |
| 606 |
ORAL DISORDER |
1 |
0.0001 |
| 607 |
ERYTHEMA |
28 |
0.0001 |
| 608 |
OFF LABEL USE |
118 |
0.0001 |
| 609 |
ARTHRALGIA |
56 |
0.0001 |
| 610 |
FEELING DRUNK |
1 |
0.0001 |
| 611 |
EYE SWELLING |
5 |
0.0001 |
| 612 |
IMMUNODEFICIENCY |
2 |
0.0001 |
| 613 |
SUNBURN |
1 |
0.0001 |
| 614 |
ORAL PAIN |
3 |
0.0001 |
| 615 |
HYPERTENSION |
28 |
0.0001 |
| 616 |
INFECTION |
19 |
0.0001 |
| 617 |
MATERNAL DRUGS AFFECTING FOETUS |
1 |
0.0001 |
| 618 |
INTERCEPTED PRODUCT ADMINISTRATION ERROR |
1 |
0.0001 |
| 619 |
PSORIASIS |
17 |
0.0001 |
| 620 |
PRURITUS |
50 |
0.0001 |
| 621 |
RENAL FAILURE CHRONIC |
1 |
0.0001 |
| 622 |
HAEMOLYSIS |
1 |
0.0001 |
| 623 |
APHTHOUS ULCER |
1 |
0.0001 |
| 624 |
THERAPY PARTIAL RESPONDER |
2 |
0.0001 |
| 625 |
ASTHENIA |
48 |
0.0001 |
| 626 |
MULTIPLE ALLERGIES |
1 |
0.0001 |
| 627 |
OCULAR HYPERAEMIA |
6 |
0.0001 |
| 628 |
GINGIVAL PAIN |
1 |
0.0001 |
| 629 |
ATRIAL FLUTTER |
1 |
0.0001 |
| 630 |
ABORTION SPONTANEOUS |
5 |
0.0001 |
| 631 |
LOCALISED INFECTION |
3 |
0.0001 |
| 632 |
RHINITIS |
1 |
0.0001 |
| 633 |
UNDERDOSE |
9 |
0.0001 |
| 634 |
OEDEMA PERIPHERAL |
15 |
0.0001 |
| 635 |
HICCUPS |
1 |
0.0001 |
| 636 |
HYPERAESTHESIA |
1 |
0.0001 |
| 637 |
HAIR DISORDER |
1 |
0.0001 |
| 638 |
PHOTOSENSITIVITY REACTION |
2 |
0.0001 |
| 639 |
SPINAL COMPRESSION FRACTURE |
1 |
0.0001 |
| 640 |
SUICIDAL IDEATION |
11 |
0.0001 |
| 641 |
DIZZINESS |
59 |
0.0001 |
| 642 |
PNEUMONIA |
38 |
0.0001 |
| 643 |
SCAR |
2 |
0.0001 |
| 644 |
DRUG INEFFECTIVE |
153 |
0.0001 |
| 645 |
ANXIETY |
33 |
0.0001 |
| 646 |
MYOPATHY |
1 |
0.0001 |
| 647 |
CARDIAC MURMUR |
1 |
0.0001 |
| 648 |
PYELONEPHRITIS |
1 |
0.0001 |
| 649 |
SKIN SWELLING |
1 |
0.0001 |
| 650 |
ABDOMINAL DISTENSION |
12 |
0.0001 |
| 651 |
VERTIGO |
7 |
0.0001 |
| 652 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
1 |
0.0001 |
| 653 |
METASTASES TO LIVER |
2 |
0.0001 |
| 654 |
PRODUCT COMMUNICATION ISSUE |
1 |
0.0001 |
| 655 |
HYPERSENSITIVITY |
21 |
0.0001 |
| 656 |
PURPURA |
1 |
0.0001 |
| 657 |
PRODUCT DOSE OMISSION ISSUE |
33 |
0.0001 |
| 658 |
PAIN OF SKIN |
3 |
0.0001 |
| 659 |
HEAVY MENSTRUAL BLEEDING |
1 |
0.0001 |
| 660 |
HIDRADENITIS |
1 |
0.0001 |
| 661 |
INCREASED TENDENCY TO BRUISE |
1 |
0.0001 |
| 662 |
UPPER RESPIRATORY TRACT INFECTION |
5 |
0.0001 |
| 663 |
BREAST CANCER STAGE I |
1 |
0.0001 |
| 664 |
CHEST DISCOMFORT |
11 |
0.0001 |
| 665 |
FLANK PAIN |
1 |
0.0001 |
| 666 |
PHOTOPHOBIA |
2 |
0.0001 |
| 667 |
ABORTION INDUCED |
1 |
0.0001 |
| 668 |
SPINAL DISORDER |
1 |
0.0001 |
| 669 |
SPUTUM DISCOLOURED |
1 |
0.0001 |
| 670 |
PAIN IN EXTREMITY |
31 |
0.0001 |
| 671 |
DISEASE RECURRENCE |
5 |
0.0001 |
| 672 |
SLEEP APNOEA SYNDROME |
2 |
0.0001 |
| 673 |
GAIT DISTURBANCE |
20 |
0.0001 |
| 674 |
AFFECT LABILITY |
1 |
0.0001 |
| 675 |
DIARRHOEA |
67 |
0.0001 |
| 676 |
ATELECTASIS |
1 |
0.0001 |
| 677 |
BLOOD PRESSURE SYSTOLIC INCREASED |
2 |
0.0001 |
| 678 |
PHARYNGEAL SWELLING |
1 |
0.0001 |
| 679 |
ASCITES |
3 |
0.0001 |
| 680 |
EMBEDDED DEVICE |
1 |
0.0001 |
| 681 |
BLOOD PRESSURE ABNORMAL |
2 |
0.0001 |
| 682 |
COMPLICATION OF DEVICE INSERTION |
2 |
0.0001 |
| 683 |
HYPOTONIA |
1 |
0.0001 |
| 684 |
SALIVARY HYPERSECRETION |
1 |
0.0001 |
| 685 |
LACRIMATION INCREASED |
3 |
0.0001 |
| 686 |
THERAPEUTIC RESPONSE DECREASED |
6 |
0.0001 |
| 687 |
ABDOMINAL PAIN |
23 |
0.0001 |
| 688 |
FEEDING DISORDER |
2 |
0.0001 |
| 689 |
INSOMNIA |
26 |
0.0001 |
| 690 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 691 |
EAR DISCOMFORT |
1 |
0.0001 |
| 692 |
THERAPY CESSATION |
5 |
0.0001 |
| 693 |
PRODUCT PREPARATION ERROR |
2 |
0.0001 |
| 694 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 695 |
WEIGHT DECREASED |
27 |
0.0001 |
| 696 |
POOR VENOUS ACCESS |
1 |
0.0001 |
| 697 |
HYPERBILIRUBINAEMIA |
1 |
0.0001 |
| 698 |
EYE DISCHARGE |
1 |
0.0001 |
| 699 |
POLLAKIURIA |
4 |
0.0001 |
| 700 |
PETECHIAE |
1 |
0.0001 |
| 701 |
PYREXIA |
33 |
0.0001 |
| 702 |
MOUTH ULCERATION |
2 |
0.0001 |
| 703 |
CLOSTRIDIUM DIFFICILE COLITIS |
1 |
0.0001 |
| 704 |
URINARY TRACT INFECTION |
16 |
0.0001 |
| 705 |
BREAST PAIN |
1 |
0.0001 |
| 706 |
BREAST CANCER METASTATIC |
1 |
0.0001 |
| 707 |
RHINORRHOEA |
6 |
0.0001 |
| 708 |
DISTURBANCE IN ATTENTION |
5 |
0.0001 |
| 709 |
DECREASED ACTIVITY |
1 |
0.0001 |
| 710 |
DEVICE DISLOCATION |
4 |
0.0001 |
| 711 |
SKIN LACERATION |
1 |
0.0001 |
| 712 |
PRODUCT DISPENSING ERROR |
2 |
0.0001 |
| 713 |
PULMONARY THROMBOSIS |
1 |
0.0001 |
| 714 |
OESOPHAGITIS |
1 |
0.0001 |
| 715 |
TREATMENT NONCOMPLIANCE |
5 |
0.0001 |
| 716 |
EXPIRED PRODUCT ADMINISTERED |
3 |
0.0001 |
| 717 |
TOOTH DISORDER |
2 |
0.0001 |
| 718 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0001 |
| 719 |
SNEEZING |
2 |
0.0001 |
| 720 |
SKIN INFECTION |
1 |
0.0001 |
| 721 |
EYE PAIN |
5 |
0.0001 |
| 722 |
REBOUND EFFECT |
1 |
0.0001 |
| 723 |
APPLICATION SITE PRURITUS |
2 |
0.0001 |
| 724 |
SCAB |
1 |
0.0001 |
| 725 |
SKIN DISCOLOURATION |
4 |
0.0001 |
| 726 |
PRODUCT SUBSTITUTION ISSUE |
5 |
0.0001 |
| 727 |
FOETAL EXPOSURE DURING PREGNANCY |
7 |
0.0001 |
| 728 |
CAESAREAN SECTION |
1 |
0.0001 |
| 729 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
2 |
0.0001 |
| 730 |
HEART RATE DECREASED |
3 |
0.0001 |
| 731 |
SEXUAL DYSFUNCTION |
1 |
0.0001 |
| 732 |
NASAL CONGESTION |
5 |
0.0001 |
| 733 |
LYMPHADENOPATHY |
3 |
0.0001 |
| 734 |
BACTERAEMIA |
1 |
0.0001 |
| 735 |
RASH ERYTHEMATOUS |
4 |
0.0001 |
| 736 |
NOCTURIA |
1 |
0.0001 |
| 737 |
PANIC ATTACK |
3 |
0.0001 |
| 738 |
ACCIDENTAL OVERDOSE |
3 |
0.0001 |
| 739 |
INJECTION SITE URTICARIA |
2 |
0.0001 |
| 740 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 741 |
SMALL INTESTINAL OBSTRUCTION |
1 |
0.0001 |
| 742 |
TENDON RUPTURE |
1 |
0.0001 |
| 743 |
CYST |
1 |
0.0001 |
| 744 |
HAIR COLOUR CHANGES |
1 |
0.0001 |
| 745 |
AGEUSIA |
2 |
0.0001 |
| 746 |
INJECTION SITE DISCOLOURATION |
1 |
0.0001 |
| 747 |
LEUKOPENIA |
4 |
0.0001 |
| 748 |
HOT FLUSH |
6 |
0.0001 |
| 749 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 750 |
TACHYCARDIA |
7 |
0.0001 |
| 751 |
INJECTION SITE IRRITATION |
1 |
0.0001 |
| 752 |
DEVICE DEPLOYMENT ISSUE |
1 |
0.0001 |
| 753 |
HYPOPHAGIA |
2 |
0.0001 |
| 754 |
ROTATOR CUFF SYNDROME |
1 |
0.0001 |
| 755 |
DRUG RESISTANCE |
2 |
0.0001 |
| 756 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
1 |
0.0001 |
| 757 |
PLATELET COUNT INCREASED |
1 |
0.0001 |
| 758 |
GASTRITIS |
2 |
0.0001 |
| 759 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 760 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 761 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
3 |
0.0001 |
| 762 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 763 |
THROAT TIGHTNESS |
2 |
0.0001 |
| 764 |
IMPAIRED GASTRIC EMPTYING |
1 |
0.0001 |
| 765 |
MALAISE |
32 |
0.0001 |
| 766 |
APPLICATION SITE RASH |
1 |
0.0001 |
| 767 |
INJECTION SITE REACTION |
5 |
0.0001 |
| 768 |
ABNORMAL DREAMS |
2 |
0.0001 |
| 769 |
ORAL DISCOMFORT |
1 |
0.0001 |
| 770 |
FEELING COLD |
2 |
0.0001 |
| 771 |
HUNGER |
1 |
0.0001 |
| 772 |
MASS |
1 |
0.0001 |
| 773 |
HEART RATE INCREASED |
7 |
0.0001 |
| 774 |
FLATULENCE |
4 |
0.0001 |
| 775 |
BRONCHOSPASM |
1 |
0.0001 |
| 776 |
ANGINA PECTORIS |
2 |
0.0001 |
| 777 |
BALANCE DISORDER |
6 |
0.0001 |
| 778 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 779 |
ANOSMIA |
1 |
0.0001 |
| 780 |
DYSPNOEA |
39 |
0.0001 |
| 781 |
COMPLICATION ASSOCIATED WITH DEVICE |
1 |
0.0001 |
| 782 |
INTENTIONAL PRODUCT MISUSE |
6 |
0.0001 |
| 783 |
COVID-19 |
12 |
0.0001 |
| 784 |
ANGIOEDEMA |
3 |
0.0001 |
| 785 |
URINARY INCONTINENCE |
2 |
0.0001 |
| 786 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 787 |
BONE LOSS |
1 |
0.0001 |
| 788 |
HALLUCINATION |
5 |
0.0001 |
| 789 |
CORONARY ARTERY DISEASE |
2 |
0.0001 |
| 790 |
BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 791 |
OSTEOPENIA |
1 |
0.0001 |
| 792 |
VISION BLURRED |
9 |
0.0001 |
| 793 |
BLOOD PRESSURE INCREASED |
10 |
0.0001 |
| 794 |
HEADACHE |
41 |
0.0001 |
| 795 |
TINNITUS |
3 |
0.0001 |
| 796 |
HYPOKALAEMIA |
3 |
0.0001 |
| 797 |
DELUSION |
1 |
0.0001 |
| 798 |
ACUTE MYELOID LEUKAEMIA |
1 |
0.0001 |
| 799 |
MENINGIOMA |
1 |
0.0001 |
| 800 |
ARRHYTHMIA |
3 |
0.0001 |
| 801 |
DYSPHAGIA |
6 |
0.0001 |
| 802 |
MOOD SWINGS |
2 |
0.0001 |
| 803 |
HIP FRACTURE |
2 |
0.0001 |
| 804 |
FATIGUE |
48 |
0.0001 |
| 805 |
BLOOD POTASSIUM INCREASED |
1 |
0.0001 |
| 806 |
METASTASES TO BONE |
1 |
0.0001 |
| 807 |
EYE DISORDER |
2 |
0.0001 |
| 808 |
BACK PAIN |
14 |
0.0001 |
| 809 |
PSYCHOMOTOR HYPERACTIVITY |
1 |
0.0001 |
| 810 |
FUNGAL INFECTION |
2 |
0.0001 |
| 811 |
SKIN DISORDER |
2 |
0.0001 |
| 812 |
CONSTIPATION |
13 |
0.0001 |
| 813 |
NAUSEA |
47 |
0.0001 |
| 814 |
FACE OEDEMA |
1 |
0.0001 |
| 815 |
CANDIDA INFECTION |
1 |
0.0001 |
| 816 |
GASTRIC DISORDER |
2 |
0.0001 |
| 817 |
ILLNESS |
6 |
0.0001 |
| 818 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 819 |
NEOPLASM PROGRESSION |
2 |
0.0001 |
| 820 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 821 |
RASH MACULAR |
2 |
0.0001 |
| 822 |
DEVICE USE ISSUE |
1 |
0.0001 |
| 823 |
LYMPHOCYTE COUNT DECREASED |
1 |
0.0001 |
| 824 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 825 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 826 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 827 |
GOUT |
1 |
0.0001 |
| 828 |
INJECTION SITE PAIN |
17 |
0.0001 |
| 829 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 830 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 831 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 832 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 833 |
DYSURIA |
2 |
0.0001 |
| 834 |
ANAPHYLACTIC REACTION |
3 |
0.0001 |
| 835 |
BRONCHITIS |
4 |
0.0001 |
| 836 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 837 |
DYSGEUSIA |
4 |
0.0001 |
| 838 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 839 |
HYPONATRAEMIA |
3 |
0.0001 |
| 840 |
DYSPNOEA EXERTIONAL |
2 |
0.0001 |
| 841 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 842 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 843 |
NEUROPATHY PERIPHERAL |
5 |
0.0001 |
| 844 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 845 |
FEELING JITTERY |
1 |
0.0001 |
| 846 |
ANAEMIA |
10 |
0.0001 |
| 847 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 848 |
HOSPITALISATION |
8 |
0.0001 |
| 849 |
DYSTONIA |
1 |
0.0001 |
| 850 |
DYSPHONIA |
3 |
0.0001 |
| 851 |
CHOKING |
1 |
0.0001 |
| 852 |
PALPITATIONS |
6 |
0.0001 |
| 853 |
BONE PAIN |
3 |
0.0001 |
| 854 |
ARTHRITIS |
4 |
0.0001 |
| 855 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 856 |
THROMBOSIS |
4 |
0.0000 |
| 857 |
DYSKINESIA |
2 |
0.0000 |
| 858 |
FLUSHING |
5 |
0.0000 |
| 859 |
INJURY ASSOCIATED WITH DEVICE |
1 |
0.0000 |
| 860 |
RIB FRACTURE |
1 |
0.0000 |
| 861 |
ACCIDENTAL EXPOSURE TO PRODUCT |
5 |
0.0000 |
| 862 |
INJECTION SITE ERYTHEMA |
6 |
0.0000 |
| 863 |
TREMOR |
8 |
0.0000 |
| 864 |
RHABDOMYOLYSIS |
2 |
0.0000 |
| 865 |
DERMATITIS |
1 |
0.0000 |
| 866 |
SKIN EXFOLIATION |
4 |
0.0000 |
| 867 |
EATING DISORDER |
1 |
0.0000 |
| 868 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 869 |
WHITE BLOOD CELL COUNT DECREASED |
5 |
0.0000 |
| 870 |
BLOOD CREATININE INCREASED |
3 |
0.0000 |
| 871 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 872 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 873 |
MELAENA |
1 |
0.0000 |
| 874 |
BLOOD PRESSURE DECREASED |
3 |
0.0000 |
| 875 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 876 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 877 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
0.0000 |
| 878 |
CHROMATURIA |
1 |
0.0000 |
| 879 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 880 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 881 |
OROPHARYNGEAL PAIN |
4 |
0.0000 |
| 882 |
COUGH |
12 |
0.0000 |
| 883 |
DISEASE PROGRESSION |
5 |
0.0000 |
| 884 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 885 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 886 |
NEURALGIA |
1 |
0.0000 |
| 887 |
EPISTAXIS |
3 |
0.0000 |
| 888 |
SYNCOPE |
4 |
0.0000 |
| 889 |
CELLULITIS |
2 |
0.0000 |
| 890 |
HAEMATEMESIS |
1 |
0.0000 |
| 891 |
INJECTION SITE SWELLING |
3 |
0.0000 |
| 892 |
ERECTILE DYSFUNCTION |
1 |
0.0000 |
| 893 |
SKIN ULCER |
1 |
0.0000 |
| 894 |
DIPLOPIA |
1 |
0.0000 |
| 895 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 896 |
NERVOUSNESS |
2 |
0.0000 |
| 897 |
SEDATION |
1 |
0.0000 |
| 898 |
SPEECH DISORDER |
2 |
0.0000 |
| 899 |
ANHEDONIA |
1 |
0.0000 |
| 900 |
ASPARTATE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 901 |
INJECTION SITE BRUISING |
3 |
0.0000 |
| 902 |
BREAST CANCER FEMALE |
1 |
0.0000 |
| 903 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 904 |
LIMB INJURY |
1 |
0.0000 |
| 905 |
PALLOR |
1 |
0.0000 |
| 906 |
MOOD ALTERED |
1 |
0.0000 |
| 907 |
HAEMATOCHEZIA |
2 |
0.0000 |
| 908 |
INFLUENZA |
4 |
0.0000 |
| 909 |
MYALGIA |
6 |
0.0000 |
| 910 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 911 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 912 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 913 |
HERPES ZOSTER |
2 |
0.0000 |
| 914 |
NEEDLE ISSUE |
1 |
0.0000 |
| 915 |
PRODUCT STORAGE ERROR |
3 |
0.0000 |
| 916 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 917 |
PREMATURE BABY |
1 |
0.0000 |
| 918 |
HEPATIC FAILURE |
1 |
0.0000 |
| 919 |
PLEURAL EFFUSION |
2 |
0.0000 |
| 920 |
INJECTION SITE RASH |
1 |
0.0000 |
| 921 |
ALANINE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 922 |
FEMUR FRACTURE |
1 |
0.0000 |
| 923 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 924 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 925 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 926 |
LOSS OF CONSCIOUSNESS |
4 |
0.0000 |
| 927 |
HYPERHIDROSIS |
4 |
0.0000 |
| 928 |
ATRIAL FIBRILLATION |
3 |
0.0000 |
| 929 |
PRODUCT DOSE OMISSION |
2 |
0.0000 |
| 930 |
CHOLELITHIASIS |
1 |
0.0000 |
| 931 |
OSTEONECROSIS |
1 |
0.0000 |
| 932 |
FALL |
10 |
0.0000 |
| 933 |
NEOPLASM MALIGNANT |
2 |
0.0000 |
| 934 |
SOMNOLENCE |
6 |
0.0000 |
| 935 |
HAEMATURIA |
1 |
0.0000 |
| 936 |
NIGHTMARE |
1 |
0.0000 |
| 937 |
RESTLESSNESS |
1 |
0.0000 |
| 938 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 939 |
COLITIS |
1 |
0.0000 |
| 940 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 941 |
SEIZURE |
3 |
0.0000 |
| 942 |
FEELING ABNORMAL |
6 |
0.0000 |
| 943 |
PROSTATE CANCER |
2 |
0.0000 |
| 944 |
DEVICE BREAKAGE |
1 |
0.0000 |
| 945 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 946 |
INFLUENZA LIKE ILLNESS |
2 |
0.0000 |
| 947 |
HYPOACUSIS |
1 |
0.0000 |
| 948 |
MENTAL DISORDER |
1 |
0.0000 |
| 949 |
DEHYDRATION |
3 |
0.0000 |
| 950 |
NO ADVERSE EVENT |
4 |
0.0000 |
| 951 |
NEUTROPENIA |
3 |
0.0000 |
| 952 |
BREAST CANCER |
2 |
0.0000 |
| 953 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 954 |
PULMONARY EMBOLISM |
2 |
0.0000 |
| 955 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 956 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 957 |
AGGRESSION |
1 |
0.0000 |
| 958 |
MALIGNANT NEOPLASM PROGRESSION |
2 |
0.0000 |
| 959 |
DEPRESSED MOOD |
1 |
0.0000 |
| 960 |
BRADYCARDIA |
1 |
0.0000 |
| 961 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
| 962 |
OVERDOSE |
4 |
0.0000 |
| 963 |
THROMBOCYTOPENIA |
2 |
0.0000 |
| 964 |
CONVULSION |
1 |
0.0000 |
| 965 |
LETHARGY |
1 |
0.0000 |
| 966 |
EMOTIONAL DISTRESS |
2 |
0.0000 |
| 967 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 968 |
RENAL FAILURE |
2 |
0.0000 |
| 969 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 970 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
3 |
0.0000 |
| 971 |
INCORRECT DOSE ADMINISTERED |
3 |
0.0000 |
| 972 |
DRUG INTERACTION |
2 |
0.0000 |
| 973 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 974 |
COMPLETED SUICIDE |
1 |
0.0000 |
| 975 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 976 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |
| 977 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 978 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 979 |
HYPOTENSION |
2 |
0.0000 |
| 980 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 981 |
HAEMORRHAGE |
1 |
0.0000 |
| 982 |
SEPSIS |
1 |
0.0000 |
| 983 |
CHILLS |
1 |
0.0000 |
| 984 |
DEATH |
7 |
0.0000 |
| 985 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 986 |
DRUG DEPENDENCE |
1 |
0.0000 |
| 987 |
DRUG DOSE OMISSION |
1 |
0.0000 |